Nano-X Imaging (Nasdaq:NNOX) - Aktienkurs, Nachrichten und Analyse

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

NNOX Aktienübersicht

Nano-X Imaging Ltd. entwickelt ein kommerzielles tomographisches Bildgebungsgerät mit einer digitalen Röntgenquelle.

NNOX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Belohnungen

Prognostiziertes jährliches Umsatzwachstum 96.29%

Risikoanalyse

Die Aktionäre wurden im vergangenen Jahr verwässert

Derzeit unrentabel und in den nächsten 3 Jahren nicht rentabel zu werden prognostiziert

Nano-X Imaging Ltd. Wettbewerber

Castle Biosciences

NasdaqGM:CSTL

US$635.8m

Longduoduo

OTCPK:LDDD

US$156.6m

DocGo

NasdaqCM:DCGO

US$327.0m

Accolade

NasdaqGS:ACCD

US$539.1m

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Nano-X Imaging
Historical stock prices
Current Share Price	US$7.84
52 Week High	US$20.57
52 Week Low	US$4.89
Beta	2.08
1 Month Change	-17.47%
3 Month Change	-23.21%
1 Year Change	-57.76%
3 Year Change	-73.58%
5 Year Change	n/a
Change since IPO	-63.87%

Aktuelle Nachrichten und Updates

Is Nano-X Imaging (NASDAQ:NNOX) Weighed On By Its Debt Load?

Apr 05

Nano-X Imaging: System Deployments Finally Begin

Apr 01

Recent updates

Nano-X Imaging Q4 2021 Earnings Preview: Insight Coming Regarding This Binary Play

Mar 30

Monday's Drop Isn't Likely The Last One For Nano-X

Dec 28

Nano-X Imaging Stock Is A No-No Buy

Oct 11

We're Interested To See How Nano-X Imaging (NASDAQ:NNOX) Uses Its Cash Hoard To Grow

Aug 20

Nanox submits 510(k) application for first version of Nanox.ARC 3-D in U.S.

Jun 17

We're Not Worried About Nano-X Imaging's (NASDAQ:NNOX) Cash Burn

May 05

Here's What Nano-X Imaging Ltd.'s (NASDAQ:NNOX) Shareholder Ownership Structure Looks Like

Mar 08

Nano-X Imaging lower 10% on additional information request by FDA on Nanox.ARC version

Feb 01

Nano-X Imaging (NASDAQ:NNOX) Is In A Strong Position To Grow Its Business

Jan 13

Nano-X Imaging and USARAD extend strategic collaboration

Jan 05

Nano-X Vision Under The X-Ray

Dec 09

What Type Of Shareholders Make Up Nano-X Imaging Ltd.'s (NASDAQ:NNOX) Share Registry?

Nov 21

Nano-X Imaging EPS misses by $0.12

Nov 09

NANO-X Imaging: Novel Technology Or Outdated Technology?

Nov 02

Aktionärsrenditen

	NNOX	US Healthcare	US Markt
7D	-6.2%	-0.4%	0.8%
1Y	-57.8%	1.2%	22.4%

Rendite im Vergleich zur Industrie: NNOX unter dem Niveau der Branche US Healthcare, die im vergangenen Jahr eine Rendite von 5.5% erzielte.

Rendite vs. Markt: NNOX hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 25.6 erzielte.

Preisvolatilität

Is NNOX's price volatile compared to industry and market?
NNOX volatility
NNOX Average Weekly Movement	9.1%
Healthcare Industry Average Movement	6.3%
Market Average Movement	5.8%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	2.8%

Stabiler Aktienkurs: NNOXDer Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: NNOXDie wöchentliche Volatilität (10%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
n/a	164	Erez Meltzer	www.nanox.vision

Nano-X Imaging Ltd. entwickelt ein kommerzielles tomographisches Bildgebungsgerät mit einer digitalen Röntgenquelle. Das Unternehmen bietet Teleradiologiedienste an und entwickelt Anwendungen der künstlichen Intelligenz, die in realen medizinischen Bildgebungsanwendungen eingesetzt werden können. Die Röntgenquelle des Unternehmens basiert auf einer digitalen Halbleiterkathode für mikroelektromechanische Systeme.

Nano-X Imaging Ltd.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Nano-X Imaging im Vergleich zum Marktanteil des Unternehmens?
NNOX grundlegende Statistiken
Marktanteil	US$468.09m
Gewinn(TTM)	-US$61.26m
Umsatz(TTM)	US$10.01m

45.3x

Kurs-Umsatz-Verhältnis

-7.4x

Kurs-Gewinn-Verhältnis

Ist NNOX zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
NNOX Gewinn- und Verlustrechnung (TTM)
Einnahmen	US$10.01m
Kosten der Einnahmen	US$17.13m
Bruttogewinn	-US$7.12m
Sonstige Ausgaben	US$54.13m
Umsatz	-US$61.26m

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	-1.06
Bruttomarge	-71.15%
Nettogewinnspanne	-611.89%
Schulden/Eigenkapital-Verhältnis	1.8%

Wie hat sich NNOX auf lange Sicht entwickelt?

Historische Performance und Vergleiche

NNOX Aktienübersicht

Belohnungen

Risikoanalyse

Nano-X Imaging Ltd. Wettbewerber

NasdaqGM:CSTL

US$635.8m

OTCPK:LDDD

US$156.6m

NasdaqCM:DCGO

US$327.0m

NasdaqGS:ACCD

US$539.1m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Nano-X Imaging Ltd. to Report Q1, 2024 Results on May 28, 2024

Is Nano-X Imaging (NASDAQ:NNOX) Weighed On By Its Debt Load?

Price target decreased by 26% to US$16.00

Full year 2023 earnings released: US$1.08 loss per share (vs US$2.17 loss in FY 2022)

Nano-X Imaging: System Deployments Finally Begin

Nano-X Imaging Ltd. to Report Q4, 2023 Results on Apr 01, 2024

Recent updates

Nano-X Imaging Ltd. to Report Q1, 2024 Results on May 28, 2024

Is Nano-X Imaging (NASDAQ:NNOX) Weighed On By Its Debt Load?

Price target decreased by 26% to US$16.00

Full year 2023 earnings released: US$1.08 loss per share (vs US$2.17 loss in FY 2022)

Nano-X Imaging: System Deployments Finally Begin

Nano-X Imaging Ltd. to Report Q4, 2023 Results on Apr 01, 2024

Nanox Receives FDA Clearance for Healthfld

New minor risk - Share price stability

Price target decreased by 16% to US$18.30

Nano-X Imaging Ltd. Announces Demise of Ran Poliakine, Founder and Non-Executive Chairman

Nano-X Imaging Ltd. Elects Nehama Ronen as A Class I Director

No longer forecast to breakeven

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Nano-X Imaging Ltd., Annual General Meeting, Dec 27, 2023

Nano-X Imaging Ltd. to Report Q3, 2023 Results on Nov 28, 2023

New minor risk - Share price stability

Consensus EPS estimates fall by 15%

Price target decreased by 12% to US$28.25

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Nano-X Imaging Ltd. to Report Q2, 2023 Results on Aug 17, 2023

Consensus revenue estimates decrease by 24%, EPS upgraded

Nano-X Imaging Ltd. Reports Unaudited Consolidated Impairment of Property and Equipment for the First Quarter Ended March 31, 2023

Nano-X Imaging Ltd. to Report Q1, 2023 Results on May 22, 2023

Consensus revenue estimates decrease by 19%, EPS upgraded

Price target decreased to US$28.25

Forecast to breakeven in 2025

Nano-X Imaging Ltd., Annual General Meeting, Dec 28, 2022

Less than half of directors are independent

Nano-X Imaging Ltd., Annual General Meeting, Dec 21, 2022

Nano-X Imaging Ltd. to Report Q3, 2022 Results on Nov 10, 2022

Nano-X Imaging Ltd Submits 510(K) Premarket Notification to the U.S. Food and Drug Administration

Nano-X Imaging gains on FDA submission for new digital X-ray technology

Consensus revenue estimates fall by 14%

Nano-X Imaging Ltd. Reports Goodwill Impairment for the Quarter Ended on June 30, 2022

Nano-X Imaging Q2 Earnings Preview

Nano-X Imaging Ltd. to Report Q2, 2022 Results on Aug 16, 2022

Nano-X: Too Controversial To Buy

Founder & Chairman notifies of intention to sell stock

Nano-X Imaging Ltd. Announces Demise of Richard Stone, Director

No longer forecast to breakeven

Consensus EPS estimates fall by 31%

Nano-X Imaging Ltd. to Report Q1, 2022 Results on May 19, 2022

Price target decreased to US$46.00

Less than half of directors are independent

Consensus revenue estimates increase by 79%

Nano-X Imaging Q4 2021 Earnings Preview: Insight Coming Regarding This Binary Play

Nano-X Imaging Ltd. to Report Q4, 2021 Results on Mar 31, 2022

Nano-X Imaging Ltd. Announces It Has Submitted with the Food and Drug Administration Q-Submission for Second Version of Multi-Source Nanox

Nano-X Imaging Ltd. Announces Issuance of American Medical Association New Category III CPT Code for Its Coronary Artery Calcium Population Health Solution

Forecast to breakeven in 2024

Monday's Drop Isn't Likely The Last One For Nano-X

Price target increased to US$50.50

Bragar Eagel & Squire, P.C. Announces Class Action Lawsuit Against Nano-X Imaging Ltd

Director notifies of intention to sell stock

Nano-X Imaging Stock Is A No-No Buy

We're Interested To See How Nano-X Imaging (NASDAQ:NNOX) Uses Its Cash Hoard To Grow

Nano-X Imaging Ltd. (NasdaqGM:NNOX) entered into a binding letter of intent to acquire USARAD Holdings Inc. and All of the Assets of MDW, LLC for $30 million.

Nano-X Imaging Ltd. (NasdaqGM:NNOX) entered into an agreement to acquire Zebra Medical Vision Ltd for $200 million.

Nano-X Imaging Ltd. Announces U.S. Food and Drug Administration 510(K) Submission for First Version of Multi-Source Nanox.ARC

Erträge & Einnahmen